Nevoid basal cell carcinoma syndrome (NBCCS) is a rare genetic disease that is manifested in a number of disorders concerning the skin, skeleton, cardiovascular and nervous systems. Various defects which can be observed at first contact with a patient visiting a dermatologist or dentist may help to diagnose this syndrome. Frequent problems with odontogenic cysts and metastatic basal-cell carcinomas result in patients being under the constant care of a specialist. This short study presents the case of 31-year-old patient with Gorlin-Goltz syndrome treated with combination therapy using CO2 laser and photodynamic therapy.
INTRODUCTION
Nevoid basal cell carcinoma syndrome(NBCCS) was described for the first time in 1960 by an American doctor, a clinical geneticist, as a set of defects with a prevalence of 1:57,000 [1] . This disease is inherited in an autosomal dominant pattern. The reason for the occurrence of numerous lesions of a basal-cell carcinoma character is the total loss of PTCH-1 gene function [2, 3] . The protein encoded by the PTCH-1 gene acts as a transmembrane receptor and contributes to the regulation of development and proliferation of stem cells in skin, skeleton and central nervous system [1] . Many symptoms of NBCCS have been described to-date and include, among others, defects in the central nervous system (Meningioma, Astrocytoma, cysts in the choroid plexus), optic tract (eyelid microcysts, hypertelorism, congenitalcataracts), urogenital system (ovary cysts and fibromas in females, hypogonadism andgynecomastia in males, L-and U-shaped kidneys), skeleton (too high sinuses aeration within the face, increased skull diameter), as well as in the alimentary and cardiovascular tracts [4, 5, 6, 7] . Diagnostics criteria were establish for rapid detection of this disease [8] in which the occurrence of two major criteria, or one major and two minor criteria are essential (Tab. 1.)
Patients suffering from NBCCS require multi-specialist neurological, gynecological, dermatological, and oral care, as well as a maxillofacial surgeon. The main dermatological problems are skin lesions of basal-cell carcinoma (BCC) nature. In order to obtain the best final esthetic effect, these patients require the combination of a few treatment methods during removal of BCC type changes. The methods used in the therapy of this kind of skin lesions include surgical, CO 2 laser, photodynamic lamp with an application of 5-aminolevulinic acid, and cryotherapy using liquid nitrogen or carbon dioxide.
CASE STUDY
In February 2011, a male 31-year old patient attended MedLaser for the first time due to numerous disseminated skin lesions within the whole body ( Fig. 1 ). Dermoscopic examination gave rise to the suspicion of changes of a basal cell carcinoma nature, which qualified the patient for surgical therapy. Histopathological examination confirmed the preliminary diagnosis. Additionally, based on morphological features and an interview, the patient was diagnosed with nevoid basal cell carcinoma syndrome. Physical examination demonstrated such features as excessively domed frontal bones, low degree hypertelorism, moderate mental retardation, epidermal cysts of eyelids, as well as fine depressions in the skin of hands.
Because of anomalies within tooth apparatus, the patient was subjected to numerous procedures within the bones of jaw and mandible. In January 2012, extensive oral and Removal of the first changes using dermatosurgical procedures was not satisfactory and resulted in the formation of keloids (Fig. 2) . Therefore, the decision was made to implement a combination therapy using CO2 laser, photodynamic lamp and 5-aminolevulinicacid. In the first stage, the CO2 laser and removal of the changes of a BCC nature by cutting and evaporation was carried out. The procedures were performed under local anesthesia with1% lidocaine. The next stage involved the use of a photodynamic lamp and5-aminolevulinicacid (ALA).
Three days after the laser therapy, 10% ALA preparation was applied to the lesion under occlusion for 3 hours. This region was then exposed to the photodynamic lamp at 630 nm wavelength for 20 minutes. The scab covering the wound after laser therapy, had to be removed prior to ALA application, The aim of this procedure was to facilitate the penetration of the preparation and polarized light to the cancer cells, which increased the therapy effectiveness. The patient was subjected to 3 PDT treatments using ALA, each at 3 week intervals.
The therapy carried out this way produced good therapeutic effects while maintaining a satisfactory esthetic result (Fig. 3) . The patient ramained under constant dermatological care, and attended regular dermoscopic examinations. The last visit was in June 2015.
DISCUSSION
Currently, there are numerous methods of basal-cell carcinoma therapy. The highest effectiveness is obtained for microsurgical therapy using the Mohs technique which seems to be indispensable in the treatment of lesions in difficult locations (low-riskBCC); in this therapy, less invasive methods do not guarantee successful prognosis [9, 10] . Unfortunately, the therapy is expensive and difficult to obtain due to the high cost of the equipment, as well as the small number of specialists who use this technique in Poland. Similar esthetic and therapeutic effects at much lower cost are guaranteed by methods such as classic surgery, CO2 laser, cryosurgery, and photodynamic lamp. It is clear that the choice of therapy method depends on the skills of the dermatologist, available equipment, and the ability to predict the final result achieved by applying the above-mentioned techniques.
The experience of our centre shows that the combination of particular methods additionally contributes to improvement of therapy effectiveness [11] . This particularly relates to CO2 laser and photodynamic lamp in combination with 10%5-aminolevulinic acid. Moreover, the combination of these two techniques should be used only in the case of changes of a surface character, confirmed with clinical and histopathological examinations (low-risk BCC). Other forms of basal-cell carcinoma, i.e. nodular, cicatricial and ulcerative, among others, should be treated surgically. 
